News

ICYMI, this week we had stories about IL-17 inhibitor durability in plaque psoriasis, benzene contamination in dry shampoo products, an interview with Muneeb Shah, DO, and more.

November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.

Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.

ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.

MGMA survey quantifies rising costs, revenues, patient encounters, and more.

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the social media phenomenon of "dermarolling."

Christopher Bunick, MD, PhD, discusses the 5th personal care product category recall, dry shampoos, due to heightened levels of benzene.

A real-world, cohort study finds popular skin rash drugs also boost moods.

Dry shampoo products were found to contain elevated levels of a cancer-causing chemical.

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Acute exposure can elevate biomarkers associated with contact dermatitis and psoriasis.

Administration pushes for vaccines and boosters for the fall.

Patients with DM may find relief from a psoriasis drug in addition to their regular therapies.

Click to see a preview of what to expect this week.

ICYMI, this week we had stories about the American Society for Dermatologic Surgery Meeting, pediatric nail disorders, generalized pustular psoriasis treatment, and more.

Lack of providers, stigma are barriers to seeking needed care, but meaningful conversations can help.

A new study shows the AD drug does not interfere with vaccinations or increase severity.

Catch up on coverage from the editors of Dermatology Times® who attended the annual ASDS Meeting.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses holistic medicine vs. western medicine for eczema treatment.

Patients saw improvements in the first-ever phase 3 trial of the blood therapy for the condition.

Saranya Wyles, MD, PhD, takes a closer look at skin aging, cellular senescence, and emerging regenerative medicine techniques at the 2022 Annual ASDS Meeting.

At the 2022 Annual ASDS Meeting, Mona Gohara, MD, highlights the importance of diversity, equity, and inclusion in the field of dermatology.

Mona Sadeghpour, MD, FAAD, chair of the State of Affairs Work Group of ASDSA, spoke at the American Society for Dermatologic Surgery Meeting about how dermatologists can stay involved in dermatologic advocacy.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses key pearls from her presentation at the American Society for Dermatologic Surgery (ASDS) Meeting.

Peter Lio, MD, talks about the difficulties and strategies used when treating patients with this common skin disorder.

How will new federal law affect lives and wallets of physicians?